Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to $4.4 million.

  • Tg Therapeutics' Gains from Investment Securities fell 582.15% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 582.15%. This contributed to the annual value of $4.5 million for FY2024, which is 482.89% down from last year.
  • Latest data reveals that Tg Therapeutics reported Gains from Investment Securities of $4.4 million as of Q3 2025, which was down 582.15% from $4.4 million recorded in Q2 2025.
  • Tg Therapeutics' 5-year Gains from Investment Securities high stood at $4.7 million for Q3 2023, and its period low was -$8.1 million during Q4 2021.
  • Its 5-year average for Gains from Investment Securities is $1.3 million, with a median of $500000.0 in 2024.
  • Data for Tg Therapeutics' Gains from Investment Securities shows a peak YoY increase of 160912.72% (in 2021) and a maximum YoY decrease of 94786.68% (in 2021) over the last 5 years.
  • Over the past 5 years, Tg Therapeutics' Gains from Investment Securities (Quarter) stood at -$8.1 million in 2021, then soared by 72.94% to -$2.2 million in 2022, then soared by 33.2% to -$1.5 million in 2023, then surged by 133.94% to $500000.0 in 2024, then skyrocketed by 772.46% to $4.4 million in 2025.
  • Its last three reported values are $4.4 million in Q3 2025, $4.4 million for Q2 2025, and $4.5 million during Q1 2025.